Thymosin beta4: structure, function, and biological properties supporting current and future clinical applications.
about
Proteomic analysis of detergent resistant membrane domains during early interaction of macrophages with rough and smooth Brucella melitensisAberrant developmental titin splicing and dysregulated sarcomere length in Thymosin β4 knockout mice.Effects of exogenous thymosin β4 on carbon tetrachloride-induced liver injury and fibrosisThymosin beta 4 prevents oxidative stress by targeting antioxidant and anti-apoptotic genes in cardiac fibroblastsThymosin-β4 prevents cardiac rupture and improves cardiac function in mice with myocardial infarction.Thymosin β4 promotes the recovery of peripheral neuropathy in type II diabetic miceCellular trafficking of thymosin beta-4 in HEPG2 cells following serum starvation.Markers of progenitor cell recruitment and differentiation rise early during ischemia and continue during resuscitation in a porcine acute ischemia model.Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterationsCardiac Repair and Regeneration: The Value of Cell Therapies.A novel dimeric thymosin beta 4 with enhanced activities accelerates the rate of wound healing.Immunoreactivity for thymosin beta 4 and thymosin beta 10 in the adult rat oro-gastro-intestinal tract.Thymosin β4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis.Controlled delivery of thymosin β4 for tissue engineering and cardiac regenerative medicine.First insights into the giant panda (Ailuropoda melanoleuca) blood transcriptome: a resource for novel gene loci and immunogenetics.Advances in the basic and clinical applications of thymosin β4.Thymosin Beta-4 Recombinant Adeno-associated Virus Enhances Human Nucleus Pulposus Cell Proliferation and Reduces Cell Apoptosis and Senescence.Thymosin beta-4 knockdown in IEC-6 normal intestinal epithelial cells induces DNA re-replication via downregulating Emi1.Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE™) model.Thymosin β₄ knockdown disrupts mitochondrial functions of SW480 human colon cancer cells.Thymosin β4 mobilizes mesothelial cells for blood vessel repair.Lipoaspirate fluid proteome: A preliminary investigation by LC-MS top-down/bottom-up integrated platform of a high potential biofluid in regenerative medicine.Recombinant adeno-associated virus carrying thymosin β4 suppresses experimental colitis in mice.Neuroprotective and neurorestorative effects of thymosin β4 treatment initiated 6 hours after traumatic brain injury in rats.Targeted delivery of thymosin beta 4 to the injured myocardium using CREKA-conjugated nanoparticles.Thymosin beta 4 protects cardiomyocytes from oxidative stress by targeting anti-oxidative enzymes and anti-apoptotic genes.A loss of profilin-1 in late-stage oral squamous cell carcinoma.Thymosin β4 alleviates renal fibrosis and tubular cell apoptosis through TGF-β pathway inhibition in UUO rat models.Neuroprotective and neurorestorative effects of thymosin β4 treatment following experimental traumatic brain injury.Quantitative analysis of thymosin β4 in whole saliva by capillary electrophoresis–mass spectrometry using multiple ions monitoring (CE-MIM-MS.).Identification of thymosins β4 and β 10 in paediatric craniopharyngioma cystic fluid.p49/STRAP, a Serum Response Factor Binding Protein (SRFBP1), Is Involved in the Redistribution of Cytoskeletal F-Actin Proteins during Glucose Deprivation.Serum Thymosin β4 Concentrations in Obstructive Sleep Apnea Syndrome Patients.Thymosin β4 Prevents Angiotensin II-Induced Cardiomyocyte Growth by Regulating Wnt/WISP Signaling.Proteomics in pediatric cystic craniopharyngioma.Thymosin β4 impeded murine stem cell proliferation with an intact cardiovascular differentiation.Thymosin β4 is a novel potential prognostic marker in gastrointestinal stromal tumors.Association between serum thymosin β4 levels of rheumatoid arthritis patients and disease activity and response to therapy.RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model.
P2860
Q27315900-0F30D09C-D5AA-40F6-B311-9042C565BAABQ30839458-61360894-91C4-4D8F-ACA3-246212951416Q33919037-9912B2D3-A54B-4CFF-B316-03F656B4E09BQ34064815-6B8DACAB-7454-4488-861B-DF8CAD1BDEBAQ34296720-68A94AC3-335E-4DB9-B4B9-F15B18D57A1DQ34393516-F87E16C7-4A7D-4D22-A25A-C510C0642743Q34962187-23229F06-4F7D-4287-A48E-2D9949F27C34Q35014310-4B958B8B-1816-4247-B4A1-2F03BDD226ABQ36597843-503DEDAD-19E3-4EF2-814D-023295C38A0AQ37152693-72491E45-8E79-43F4-9F51-F01D989CE2ABQ37221061-84760E51-EAD9-45F3-88DC-9109892CD332Q37224104-6BBB4970-74FC-4132-8DAA-F68F6D169C2BQ37315924-9140AB56-CEC0-4BD4-9550-C368B40FD2FFQ38050451-2AB23732-AFCB-4690-8673-4D53D33030B8Q38468317-9D9564A6-BE8C-4A99-9C03-F28125F18C06Q38533845-1C1DF059-8460-4DE4-B903-03B6FA1A0A23Q38869952-9DA2A711-116B-4977-86C2-D147CEC27CA1Q39016676-CC64E7C8-0FCB-42FE-BF7C-D6AD94608964Q39188067-8194BEE6-5601-443B-B705-D29DCB63B4BBQ39525579-D35E144A-E594-4810-B29D-BCBE8E462D91Q39540256-A66480B5-9FA0-4BD0-B99C-29A816538185Q40156619-047C1AC2-562B-4463-98AF-1DC06911C07CQ40362677-1B1354A7-2878-4F3B-9B7E-5CB1F6EEA65EQ41832205-5992D6D2-1DEC-42AF-80EE-95DE7AFC4549Q42044067-AB683139-2642-4107-BBCA-297E6232A291Q42261788-55AB6B7D-2D5E-4E53-8696-D52CE80BB502Q42501962-EAD0BC14-A6CC-42DC-A89F-2EC452B0CBDEQ42672184-CE599A6A-8ACA-4A8B-8241-9BFEC72334C7Q42775909-D64EE143-81E3-4762-9CBF-38D9BAB311F5Q44795924-C400502B-E71E-4CA3-A022-2E82DCDD08A2Q45783398-0901D6E1-FFC6-4B2E-8275-DB377BE89F33Q47348476-34B2FFCA-7E54-42BC-9F1B-80141AC06707Q47866837-258E6042-500C-4175-84B2-FF704B751AEAQ48069392-C273BB0B-76A4-49DD-B6AB-7643081A9430Q48269466-9C6CA2B9-3C12-46A0-BD7F-1D93F564ECECQ48640600-C21D279A-0C97-45A0-941D-18D1605B9B8EQ53152111-C9990E37-FA8B-427C-9C94-B8D55423B4D5Q53373730-4FCD079F-593E-43E6-967B-152C090960D2Q55618002-8C4627A8-DBA6-46E2-84B9-8A109DEB0553
P2860
Thymosin beta4: structure, function, and biological properties supporting current and future clinical applications.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Thymosin beta4: structure, fun ...... future clinical applications.
@ast
Thymosin beta4: structure, fun ...... future clinical applications.
@en
Thymosin beta4: structure, fun ...... future clinical applications.
@nl
type
label
Thymosin beta4: structure, fun ...... future clinical applications.
@ast
Thymosin beta4: structure, fun ...... future clinical applications.
@en
Thymosin beta4: structure, fun ...... future clinical applications.
@nl
prefLabel
Thymosin beta4: structure, fun ...... future clinical applications.
@ast
Thymosin beta4: structure, fun ...... future clinical applications.
@en
Thymosin beta4: structure, fun ...... future clinical applications.
@nl
P2093
P1476
Thymosin beta4: structure, fun ...... future clinical applications.
@en
P2093
Christian Allan
David Crockford
Janet Angel
Nabila Turjman
P2860
P304
P356
10.1111/J.1749-6632.2010.05492.X
P407
P577
2010-04-01T00:00:00Z